"10.1371_journal.pone.0064257","plos one","2013-05-21T00:00:00Z","Jonathan Plumb; Laura Robinson; Simon Lea; Antonia Banyard; John Blaikley; David Ray; Andrea Bizzi; Giorgina Volpi; Fabrizio Facchinetti; Dave Singh","National Institute for Health Research Translational Research Facility, Manchester Academic Health Science Centre, University Hospital of South Manchester Foundation Trust, University of Manchester, Manchester, United Kingdom; School of Medicine, University of Manchester, Manchester, United Kingdom; Chiesi Pharmaceuticals, Parma, Italy","Conceived and designed the experiments: JP LR DS SL GV FF AB DR. Performed the experiments: JP LR SL AB GV FF AB JB. Analyzed the data: JP LR SL GV FF AB. Contributed reagents/materials/analysis tools: GV FF AB. Wrote the paper: JP DS SL GV FF AB DR.","We have the following interests. Dr. Singh has received sponsorship to attend international meetings, honoraria for lecturing or attending advisory boards, and research grants from various pharmaceutical companies including AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Almirall, Forest, Pfizer, UCB, Novartis, and Cipla. Chiesi Pharmaceuticals funded this study and is the employer of Dr. Bizzi, Dr. Volpi and Dr. Facchinetti. Chiesi pharmaceutical provided a years salary for Dr Plumb. There are no patents, products in development or marketed products to declare. This does not alter our adherence to all the PLoS ONE policies on sharing data and materials, as detailed on-line in the guide for authors.","2013","05","Jonathan Plumb","JP",10,TRUE,8,7,6,7,TRUE,TRUE,FALSE,0,NA,FALSE
